Irina Ostrovnaya

Also affiliated with Cancer Research And Biostatistics

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 40 papers. Top paper: “Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial”.

Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial

Journal of Clinical Oncology(2022)10.1200/jco.21.01485

N/A

3.3DataRank · unranked

100 citations

Michael Lattanzi, Karissa Whiting, Hikmat Al‐Ahmadie, Colleen Quinlan, Min Yuen Teo +34 more

Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma

British Journal of Cancer(2021)10.1038/s41416-020-01244-2

N/A

1.6DataRank · unranked

40 citations

Hikmat Al‐Ahmadie, Kenneth Seier, Christopher Tully, Ashley Marie Regazzi, Eugene J. Pietzak +15 more

Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02518-x

N/A

1.3DataRank · unranked

58 citations

Bharat Burman, Swati Jain, Conall Fitzgerald, Eric J. Sherman, Lara Dunn +24 more

Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.05.005

N/A

0.937DataRank · unranked

33 citations

Brendan J. Guercio, Arshi Arora, Xueli Hao, Ashley Marie Regazzi, Timothy F. Donahue +25 more

End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer

Journal of Clinical Oncology(2025)10.1200/jco-25-01608

N/A

0.674DataRank · unranked

20 citations

Matthew D. Galsky, Nazlı Dizman, David H. Aggen, Neeraj Agarwal, Hikmat Al‐Ahmadie +39 more

Genomic heterogeneity as a barrier to precision oncology in urothelial cancer

Cell Reports(2022)10.1016/j.celrep.2022.111859

N/A

0.648DataRank · unranked

74 citations

Ziyu Chen, Hannah Wise, Andrew T. Lenis, Shweta S. Chavan, Mark T.A. Donoghue +20 more

Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications

Modern Pathology(2024)10.1016/j.modpat.2024.100557

N/A

0.646DataRank · unranked

18 citations

Karissa Whiting, Min-Yuen Teo, Jacob E. Tallman, Gamze Gokturk Ozcan, Merve Başar +21 more

A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response

Nature Communications(2020)10.1038/s41467-020-17965-0

N/A

0.631DataRank · unranked

66 citations

Kyrollis Attalla, Renzo G. DiNatale, Irina Ostrovnaya, Jessica Flynn, Kyle A. Blum +12 more

Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts

Nature Communications(2020)10.1038/s41467-020-15885-7

N/A

0.612DataRank · unranked

58 citations

Wenhuo Hu, François Audenet, Nima Almassi, Aphrothiti J. Hanrahan, Katie S. Murray +32 more

Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3403

N/A

0.604DataRank · unranked

55 citations

Vignesh Ravichandran, Samantha Brown, Syed M. Alam, Andrew Katims, Hong Truong +25 more

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma

Cancer Discovery(2022)10.1158/2159-8290.cd-21-0925

N/A

0.529DataRank · unranked

33 citations

Lynda Vuong, Josef Leibold, Nicholas H. Chakiryan, Michael Curry, Fengshen Kuo +31 more

Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma

European Urology(2025)10.1016/j.eururo.2025.04.008

N/A

0.489DataRank · unranked

25 citations

Ziyu Chen, Karissa Whiting, Irina Ostrovnaya, Andrew T. Lenis, Timothy N. Clinton +26 more

Obesity-dependent selection of driver mutations in cancer

Nature Genetics(2024)10.1038/s41588-024-01969-3

N/A

0.442DataRank · unranked

18 citations

Venise Jan Castillon, Michele Waters, Chris Fong, Tricia Park, Sonia Boscenco +10 more

Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1006

N/A

0.416DataRank · unranked

15 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6089

N/A

0.360DataRank · unranked

10 citations

R. Michael Tuttle, Ravinder K. Grewal, Eric J. Sherman, Shrujal S. Baxi, Laura Boucai +14 more

Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1064

N/A

0.344DataRank · unranked

7 citations

Joris L. Vos, Nora Katabi, Fengshen Kuo, Zaineb Nadeem, Maximilian Linxweiler +8 more

Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer

Nature Communications(2025)10.1038/s41467-025-67643-2

N/A

0.292DataRank · unranked

6 citations

Xinran Tang, Jordan Eichholz, Andrew McPherson, Jasmine Thomas, Karan Nagar +23 more

Natural History and Genomic Landscape of Chemotherapy-Resistant Muscle-Invasive Bladder Cancer

JCO Precision Oncology(2024)10.1200/po.23.00274

N/A

0.292DataRank · unranked

6 citations

Karissa Whiting, Vignesh Ravichandran, Jacob E. Tallman, Syed M. Alam, Carissa Chu +29 more

Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6587

N/A

0.241DataRank · unranked

4 citations

Eric J. Sherman, Anuja Kriplani, Loren S. Michel, Lara Dunn, James Fetten +14 more

Biomarkers of response to neoadjuvant atezolizumab with gemcitabine and cisplatin in muscle-invasive bladder cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4584

N/A

0.165DataRank · unranked

2 citations

Alexander Solovyov, Jayon Lihm, Colleen Quinlan, Karissa Whiting, Hao Li +15 more

Long-term oncologic outcomes of metastatic clear-cell renal cell carcinoma after local therapy alone

Urologic Oncology Seminars and Original Investigations(2025)10.1016/j.urolonc.2025.08.004

N/A

0.104DataRank · unranked

1 citations

Mark Dawidek, Andrea Knežević, Marc Ganz, Lina Posada, Yash S. Khandwala +13 more

Resource-efficient pooled sequencing expands translational impact in solid tumors

Kidney Cancer Journal(2021)10.52733/kcj18n2.a1

N/A

0.104DataRank · unranked

1 citations

Roy Mano, Vladimir Makarov, Nicole Rusk, Esther Drill, Andrew Winer +13 more

A phase II study of lenvatinib plus pembrolizumab in patients with recurrent/metastatic salivary gland cancers.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.6103

N/A

0DataRank · unranked

0 citations

Eric J. Sherman, Anuja Kriplani, James Fetten, Loren S. Michel, Michael Hwang +6 more

Preoperative nomogram predicting 12-year probability of metastatic renal cancer – evaluation in a contemporary cohort

Urologic Oncology Seminars and Original Investigations(2020)10.1016/j.urolonc.2020.07.019

N/A

0DataRank · unranked

12 citations

Cihan Düzgöl, Maz Ganat, Debra A. Goldman, Kyle A. Blum, Andrew W. Silagy +14 more

Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2020.02.014

N/A

0DataRank · unranked

46 citations

Christopher Tully, Emily C. Zabor, Bernard H. Bochner, Guido Dalbagni, Harry W. Herr +8 more

A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated Liposarcoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-19-2486

N/A

0DataRank · unranked

14 citations

Ana Velez, Jordan Rios, Bernadette Laxa, David Shum, Penelope D. Ruiz +9 more

Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma – An exploratory analysis

Urologic Oncology Seminars and Original Investigations(2021)10.1016/j.urolonc.2021.08.018

N/A

0DataRank · unranked

10 citations

Cihan Düzgöl, Maz Ganat, Debra A. Goldman, Kyle A. Blum, Andrew W. Silagy +14 more

Identifying prognostic pairwise relationships among bacterial species in microbiome studies

PLoS Computational Biology(2021)10.1371/journal.pcbi.1009501

N/A

0DataRank · unranked

1 citations

Axel Martin, Irina Ostrovnaya, Sean M. Devlin

Resource-efficient pooled sequencing expands translational impact in solid tumors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.06.447265

N/A

0DataRank · unranked

0 citations

Roy Mano, Vladimir Makarov, Nicole Rusk, Esther Drill, Andrew Winer +13 more

Neoadjuvant nivolumab (N) +/- ipilimumab (I) in cisplatin-ineligible patients (pts) with muscle-invasive bladder cancer (MIBC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.498

N/A

0DataRank · unranked

12 citations

Eugene J. Pietzak, Samantha Brown, Jie‐Fu Chen, Vanessa Peters, Ashley Marie Regazzi +15 more

Novel Genetic Subtypes of Urothelial Carcinoma With Differential Outcomes on Immune Checkpoint Blockade

Journal of Clinical Oncology(2023)10.1200/jco.22.02144

N/A

0DataRank · unranked

18 citations

Mahdi Golkaram, Samuel A. Funt, Hikmat Al‐Ahmadie, Shannon Kaplan, Fan Song +11 more

Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma

Urologic Oncology Seminars and Original Investigations(2023)10.1016/j.urolonc.2023.12.003

N/A

0DataRank · unranked

6 citations

Lennert Eismann, Charlie White, Juan Arroyave Villada, Sari Khaleel, Irina Ostrovnaya +13 more

Adverse pathologic features impact survival outcomes for small renal masses following nephrectomy

Urologic Oncology Seminars and Original Investigations(2023)10.1016/j.urolonc.2023.06.010

N/A

0DataRank · unranked

1 citations

Hong Truong, Song Jiang, Paul K-Lee, Benjamin Davelman, Danielle Gordon +8 more

Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

(2023)10.1158/1078-0432.c.6532764

N/A

0DataRank · unranked

0 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Data from A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated Liposarcoma

(2023)10.1158/1078-0432.c.6531242.v1

N/A

0DataRank · unranked

0 citations

Ana Velez, Jordan Rios, Bernadette Laxa, David Shum, Penelope D. Ruiz +9 more

Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

(2023)10.1158/1078-0432.c.6532764.v1

N/A

0DataRank · unranked

0 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Data from A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated Liposarcoma

(2023)10.1158/1078-0432.c.6531242

N/A

0DataRank · unranked

0 citations

Ana Velez, Jordan Rios, Bernadette Laxa, David Shum, Penelope D. Ruiz +9 more

Sample Site Impacts RNA Biomarkers for Renal Cell Carcinoma

European Urology(2024)10.1016/j.eururo.2024.09.004

N/A

0DataRank · unranked

4 citations

Amy Xie, Cerise Tang, Andrea Knežević, Irina Ostrovnaya, Fengshen Kuo +4 more

Obesity shapes selection for driver mutations in cancer

medRxiv(2024)10.1101/2024.01.10.24301114

N/A

0DataRank · unranked

1 citations

Venise Jan Castillon, Michele Waters, Chris Fong, Tricia Park, Sonia Boscenco +7 more

Phase I Study of Everolimus in Combination with Gemcitabine and Split-Dose Cisplatin in Advanced Urothelial Carcinoma

UNC Libraries(2024)10.17615/6gs3-hm85

N/A

0DataRank · unranked

0 citations

Irina Ostrovnaya, Matthew I. Milowsky, Jonathan E. Rosenberg, Wassim Abida, Dean F. Bajorin +6 more